Most Recent
Mayne Pharma and US drug maker Cosette have agreed to postpone the start of trial in a case over the termination of a $672 million merger to allow for late amendments.
Mayne Pharma has denied US drug maker Cosette's claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger.
A court has heard US drug maker Cosette may amend its case to accuse Adelaide's Mayne Pharma of continuous disclosure breaches in their battle over the termination of their $672 million merger.
Mayne Pharma has said it may seek to shut out US drug maker Cosette's expert evidence in proceedings over the purported termination of their $672 million merger.
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
The judge overseeing class actions against Uber has approved a $271.8 million settlement, which includes an $82 million deduction for the funder and $39 million for the firm that ran the cases.
A judge has allowed a class action against CBA and its former wealth management arm Colonial First State to add claims based on a novel theory of corporate responsibility that has implications for companies’ use of AI.
Two firms representing some Rio Tinto shareholders have lost their bid to intervene in Energy Resources' fight to renew its lease for the Jabiluka uranium mine in the Northern Territory.
Almost 7,000 taxi drivers who did not sign up to two class actions against Uber by the deadline are asking the court for a cut of a $272 million settlement, with a judge questioning what she “unleashed” when sending out the notice of settlement.